Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Nifedipine measurement |
Component |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine adverse reaction |
Causative agent (attribute) |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Allergy to nifedipine |
Causative agent (attribute) |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Product containing precisely nifedipine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 30mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 60mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 10mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 20mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 10mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 30mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 60mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 20mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Product containing precisely nifedipine 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Nifedipine 90mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Product containing nifedipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50mg / nifedipine 20mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Product containing atenolol and nifedipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Allergy to nifedipine |
Causative agent (attribute) |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 5 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 10 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 20 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 90mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
|
Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Nifedipine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely nifedipine 10 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 10 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 60 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 60 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 30 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 30 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 30 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 30 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 40 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 40 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 20 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 20 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 5 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 10 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely nifedipine 20 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 30 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine 60 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing atenolol and nifedipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing only atenolol and nifedipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Nifedipine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing only nifedipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing only nifedipine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Atenolol and nifedipine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
1 |
Product containing lidocaine and nifedipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
2 |
Product containing only lidocaine and nifedipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
2 |
Product containing lidocaine and nifedipine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine and nifedipine only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine 15 milligram/1 gram and nifedipine 3 milligram/1 gram conventional release rectal cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine 15 milligram/1 gram and nifedipine 3 milligram/1 gram conventional release rectal cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Nifedipine (substance) |
Inferred relationship |
Some |
2 |